| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.009 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.00037 | 1 |